German Court Affirms Void Of Medix Testing Patent

Law360, New York (March 7, 2011, 8:23 PM EST) -- Medical device company AmniSure International LLC announced Friday that Germany's highest court upheld the invalidation of Medix Biochemica's patent for a testing procedure to diagnose ruptured fetal membranes, ending the parties' long-running infringement dispute.

The Federal Court of Justice of Germany affirmed the German Patent Court's ruling that the patent for Medix's Actim PROM rapid test was null and void due to its lack of an inventive step, according to AmniSure.

Under the European Patent Convention, every valid patent must involve an inventive step proving that...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.